Diversity in Bio Series
BioOhio proudly supports all efforts to increase diversity and inclusion within the bioscience and healthcare industries and invites you to join us for the 2020 Diversity in Bioscience Series. These events will feature a diverse and dynamic group of speakers providing in-depth insights about their professional journeys, negotiating strategies, mentorship & sponsorship, and STEM initiatives.
May 14 – Virtual/Online Event
The first Diversity in Bioscience & Healthcare event of 2020 will take place virtually on May 14 at 5pm. The engaging discussion, focused on generational diversity, will include special guests Julie Kampf, CEO & Chief Possibilities Officer, JBK Associates and Jan Rosenbaum, PhD, President, CEO, and CSO, Kurome Therapeutics. The keynote conversation will be facilitated by the talented Brooke Cartus, Director of Business Development and Senior Facilitator, ImprovEdge.
We will include fun and unique ways to network and connect with those who join the event.
Facilitated via Zoom, instructions to join will be sent in the confirmation after you register.
This event is brought to you by BioOhio in partnership with the Columbus chapter of the Healthcare Businesswomen’s Association (HBA).
5:00 pm – C-Suite Conversation with the two featured guests, led by Brooke Cartus
6:00 pm – Adjournment
This event is FREE to attend!
Brooke Cartus, Director of Business Development and Senior Facilitator, ImprovEdge
Brooke Cartus is the Director of Business Development and Senior Facilitator at ImprovEdge. A graduate of the The Michael E. Moritz College of Law at The Ohio State University, Brooke is a licensed attorney in the state of Ohio. She has been published in numerous publications including the Berkeley Journal of Gender, Law & Justice and the Huffington Post.
Julie Kampf, CEO, Chief Possibilities Officer & Board Talent Champion, JBK Associates
Julie Kampf founded JBK Associates International, Inc. in 2003 to create an executive talent solutions organization that pushes the boundaries way beyond the limitations of standard executive search. Her success has made JBK a diversity leader honored with dozens of awards, valued by the Fortune 500 companies and other organizations that seek its expertise in building high-performance teams, and accepted as a member of Amrop (Amrop JBK), one of the world’s largest retained executive search partnerships. Julie earned a BA in Political Science from the University of Rhode Island, where she minored in Marketing.
Jan Rosenbaum, PhD, President & CEO; Chief Scientific Officer, Kurome Therapeutics
Dr. Jan Rosenbaum is an experienced drug development professional with more than 25 years of technical management expertise in Pharma & Biotech in the development of small molecule, peptide, and protein therapeutics. After taking early retirement from P&G Pharmaceuticals, she joined CincyTech in 2009 as Director of Life Sciences with responsibility for creating life science startup companies in the SW Ohio region. She holds a Visiting Scholar position in the University of Cincinnati’s Department of Pharmacology & Systems Physiology, co-creating and teaching a graduate level Drug Discovery Course, in addition to lecturing across OH on the Value Proposition in Therapeutics Innovation. She received her PhD from University of California, San Francisco and did a Postdoctoral Fellowship in Clinical Pharmacology at Stanford University.